North American Scientific Inc - Current report filing (8-K)
December 11 2007 - 1:44PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
December
5, 2007
Date
of
Report (Date of earliest event reported)
NORTH
AMERICAN SCIENTIFIC, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
0-26670
|
51-0366422
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
20200
Sunburst Street, Chatsworth, California 91311
(Address
of principal executive offices) (Zip Code)
(818)
734-8600
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
□
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
□
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
□
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
□
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
On
December 5, 2007, the Board of Directors of North American Scientific, Inc.
(the
“Company”) amended the bylaws of the Company (the “Bylaws”), effective
immediately. Section 6 of the Bylaws now enables the Board of Directors to
authorize the issuance of uncertificated shares of the Company’s capital stock.
The purpose of the amendments to Section 6 are to satisfy the requirement of
The
Nasdaq Stock Market, Inc. that shares of the Company’s capital stock be eligible
by January 1, 2008 for a Direct Registration Program operated by a
clearing agency registered under Section 17A of the Securities Exchange Act
of 1934.
A
copy of
the Bylaws, as amended to date, is filed as Exhibit 3.1 to this report and
is incorporated by reference into this Item 5.03.
Item
9.01 Financial Statements and Exhibits.
|
|
(d)
Exhibits
|
|
|
|
|
|
|
|
|
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
|
|
Exhibit
3.1
|
|
Bylaws
of the Company (restated in electronic format as of December 5,
2007).
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
NORTH
AMERICAN SCIENTIFIC, INC.
|
|
|
|
|
Date:
December
11, 2007
|
By:
|
/s/ John
B.
Rush
|
|
|
Name:
John
B. Rush
|
|
|
Title: President and Chief Executive
Officer
|
EXHIBIT
INDEX
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
Exhibit
3.1
|
|
Bylaws
of the Company (restated in electronic format as of December 5,
2007).
|
North American Scientific (MM) (NASDAQ:NASI)
Historical Stock Chart
From Jan 2025 to Feb 2025
North American Scientific (MM) (NASDAQ:NASI)
Historical Stock Chart
From Feb 2024 to Feb 2025
